The Director General of the National Institute of Pharmaceutical Research and Development, NIPRD, Karniyus Gamaniel, has called for improved capital funding of research institutions in Nigeria.
Mr. Gamaniel, a professor of pharmacology, made the call at a press briefing in Abuja on Friday. He said the institution had never received more than 50 per cent of its appropriated budgets in the past six years.
“We have never received more than 50 per cent of whatever is usually appropriated to the institution”, he said.
“On aggregate, we were appropriated N1.587billion over six years, and what was released on aggregate is N744.856million. So the aggregate percentage released was 46.92 per cent”.
The director-general had recently been accused of misappropriating $514,000.36 (N77.10million) from a sum of $744,000.38 the World Bank gave the institute to develop anti-diabetic phytomedine.
Explaining the struggle of the institute, the deputy chairman of its research and development committee, Kunle Olobayo, said “For 2016, the fund appropriated was N48million capital and so far we have received N20.4million.”
“Let’s always contextualize figures. You can see that we are coming from appropriation of N100million or N200million and so on, don’t forget the exchange rate of Naira then compared to now when the exchange rate is high.
“Our appropriation is N48 million, which is actually less than $80,000 for a whole year for this institution”.
Mr. Olobayo, a professor, added that “The dollar value is important because everything we use for research in this institution is imported, glassware etc”
Speaking on the actual cost needed to run the institution, the Director General said that “From our own calculation, our estimate is precisely N269 million to run this place.
“Although, this was as at 2015, but as it is now with the exchange rate, it will be higher”.
The Deputy Chairman also addressed the issue of the challenges faced from the producers of herbal medicine.
“The first one is poor documentation. There has to be some form of document for us to be able to give a particular medicine to human”, Mr. Olobayo explained.
“Also, there are unrealistic expectations. So even when they come to us, they think you can get results that will become money for them in one week, two months.
“The process of research and development is slow and deliberate. They don’t like that”, he said.
The director general however called on the federal government to provide funds and support for research institutes like NIPRD.
“The major challenge of this institution is grossly inadequate capital cost. We need funds to carry out research and keep the institution running,” he said.
“We call on the government to provide funds and supports to the institution to enable effective operation.”